PHASE 1
NSE: CIPLAPharmaceuticals

Cipla Limited

Industry: Respiratory & Generics·Market Cap: ₹1.22 Lakh Cr
Halal
AAOIFI Standard Verdict

Is CIPLA halal? Yes — According to AAOIFI standards, this stock is Shariah-compliant.

Market Valuation & Pricing

NSE Quote
Market Price
₹1,485.00
As of 7 Nov 2026
Market Capitalization
₹1.22 Lakh Cr
Used as denominator for Shariah debt & cash caps
Price-to-Earnings (P/E)
27.4x
Trailing 12-month valuation multiple
52-Week Range51% of range
Low: ₹1,202.85High: ₹1,752.30

4-Quarter Shariah Compliance Trend

Illustrative trend · Based on quarterly NSE filings

Consistently Compliant (≤ 20%)
Debt Ratio Track30% AAOIFI Limit
Illustrative trend · Based on quarterly NSE filings

Financial Ratios Breakdown (AAOIFI)

Analysis of 3 core Shariah financial ratios based on audited quarterly balance sheet filings:

DEBT

Interest-bearing Debt / Market Cap

Pass
0.70%actual
Allowed Limit≤ 30%
CASH

Cash & Interest Securities / Market Cap

Pass
6.07%actual
Allowed Limit≤ 30%
INCOME

Non-Halal Revenue / Total Revenue

Pass
0.00%actual
Allowed Limit≤ 5%

Tazkiyah (Dividend Purification)

0.00% Required
0.00% purification required. According to audited filings, CIPLA has zero reported impermissible non-core income.

Methodology Comparison

Compare standard AAOIFI vs. Tayyib Taqwa Screen:

StandardVerdictDebt RatioCash / LiquidityImpure IncomeSector Check
AAOIFI Standard
Global Islamic Benchmark (≤30% / ≤5%)
Halal0.70% (≤30%)6.07% (≤30%)0.00% (≤5%)Pharmaceuticals
Taqwa Mode
Strict Screen (≤20% / ≤1%)
Halal0.70% (≤20%)6.07% (≤20%)0.00% (≤1%)Permissible

Filing & Source Information

Primary SectorPharmaceuticals
Sub-IndustryRespiratory & Generics
Data Freshness7 Nov 2026
Primary SourceNSE / Yahoo Financials

Important Disclaimer: This screening is for informational purposes only and does not constitute a formal fatwa or investment recommendation. Always consult a qualified Shariah scholar and a certified financial advisor before making investment decisions. Read our full methodology →

Other Pharmaceuticals Stocks